Prognosis
Regeneron Says Trump Test Results May Show Drug’s Antibodies
President Donald Trump walks out of Walter Reed National Military Medical Center on Oct. 5.
Photographer: Chris Kleponis/Polaris Images/Bloomberg
This article is for subscribers only.
Regeneron Pharmaceuticals Inc. said that the presence of antibodies in President Donald Trump’s blood could be the result of him taking the company’s experimental Covid-19 treatment last week.
Sean Conley, the president’s physician, said in a memo summarizing the president’s health on Wednesday that detectable levels of SARS CoV-2 antibodies had been found in a sample drawn Monday. Conley said antibodies weren’t detected on Thursday.